Concepedia
Statistics
Publications
69
Citations
3K
H-Index
31
Active since
1949
Affiliations
Janssen (United States)(Current)
Wilmington University
AstraZeneca (United States)
Columbia University
Johnson & Johnson (United States)
David M. Kern is an author at Janssen (United States) specializing in medicine, pharmacotherapy, and pharmacy.
Publications per year
1949–2025
T Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected Women
Robert C. Kaplan, Elizabeth Sinclair, Alan Landay et al. · The Journal of Infectious Diseases · 2011 · 291 citations · Full text
Veterinary Medicine, Immunology, Clinical Immunology +15
Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8
Lauren M. Ellman, Raymond F. Deicken, Sophia Vinogradov et al. · Schizophrenia Research · 2010 · 232 citations · Full text
Life Sciences, Neurobiology, Neuroscience +16
Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns—NHANES 2007–2012
Bingcao Wu, Kelly Bell, Amy H. Stanford et al. · BMJ Open Diabetes Research & Care · 2016 · 215 citations · Full text
Medicine, Internal Medicine, Nephrology +15
Prenatal Exposure to Maternal Infection and Executive Dysfunction in Adult Schizophrenia
Alan S. Brown, Sophia Vinogradov, William S. Kremen et al. · American Journal of Psychiatry · 2009 · 175 citations · Full text
Medicine, Infectious Diseases, Neurobiology +14
The Potential of the Uranium (V), Uranium (VI) Couple and the Kinetics of Uranium (V) Disproportionation in Perchlorate Media
David M. Kern, E. F. Orlemann · Journal of the American Chemical Society · 1949 · 146 citations
Natural Sciences, Chemistry, Analytical Chemistry +8
1–5 of 69